Sarmento Ayane Cristine, Fernandes Fabíola Sephora, Marconi Camila, Giraldo Paulo César, Eleutério-Júnior José, Crispim Janaina C, Gonçalves Ana Katherine
Programa de Pos-Graduacao em Ciencias da Saude, Universidade Federal do Rio Grande do Norte (UFRN), Natal, RN, BR.
Departamento de Analises Clinicas e Toxicologia, Universidade Federal do Rio Grande do Norte, Natal, RN, BR.
Clinics (Sao Paulo). 2020;75:e1750. doi: 10.6061/clinics/2020/e1750. Epub 2020 Aug 3.
We aimed to evaluate the effectiveness of microablative fractional radiofrequency (MAFRF) in the non-hormonal treatment of genitourinary syndrome of menopause.
We examined the cases of 55 postmenopausal women before and after treatment with regard to their vaginal health index (VHI), vaginal microbiota, vaginal pH, and cell maturation. Three applications of MAFRF were performed in the vagina/vaginal introitus. During the treatment, six vaginal smears were obtained and stained with the Papanicolaou stain for determining the degree of cell maturation and with Gram stain for classification of vaginal flora, as per the criteria of Spiegel and Amsel. For vaginal pH determination, pH indicator strips were applied against the vaginal wall. Statistical analysis was performed using SPSS for Windows (version 17.0). Data were reported as mean±standard deviation. The differences were analyzed using the statistical method of generalized estimation equations with autoregressive correlation structure "1" and robust standard errors.
The mean age was 59.8±4.2 years, and the mean time of menopause was 15.4±4.5 years. After treatment, there was an increase in the percentage of Lactobacillus spp. (p<0.001). Consequently, there was a progressive decrease in vaginal pH during the treatment (p<0.001). Regarding cell maturation, there was a decrease in the percentage of parabasal cells (p=0.001) and an increase in the rate of superficial cells (p<0.001). Additionally, there was an improvement in the VHI index. The mean VHI values before and after treatment were 13.2±5.6 and 22.5±3.7, respectively (p<0.001).
MAFRF treatment is well tolerated and leads to improvement in the vaginal microenvironment.
我们旨在评估微剥脱性分次射频(MAFRF)在绝经后泌尿生殖综合征非激素治疗中的有效性。
我们检查了55名绝经后女性在治疗前后的阴道健康指数(VHI)、阴道微生物群、阴道pH值和细胞成熟度。在阴道/阴道口进行了三次MAFRF治疗。治疗期间,按照Spiegel和Amsel的标准,获取了六次阴道涂片,分别用巴氏染色法确定细胞成熟度,用革兰氏染色法对阴道菌群进行分类。对于阴道pH值的测定,将pH试纸贴在阴道壁上。使用Windows版SPSS(版本17.0)进行统计分析。数据以均值±标准差表示。使用具有自回归相关结构“1”和稳健标准误的广义估计方程统计方法分析差异。
平均年龄为59.8±4.2岁,平均绝经时间为15.4±4.5年。治疗后,乳酸杆菌属的百分比增加(p<0.001)。因此,治疗期间阴道pH值逐渐降低(p<0.001)。关于细胞成熟度,基底旁细胞的百分比降低(p=0.001),表层细胞的比例增加(p<0.001)。此外,VHI指数有所改善。治疗前后的平均VHI值分别为13.2±5.6和22.5±3.7(p<0.001)。
MAFRF治疗耐受性良好,可改善阴道微环境。